The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II trial with expansion of patients at the MTD trial of olaparib plus weekly (metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients.
 
Saul E. Rivkin
Stock and Other Ownership Interests - Johnson & Johnson; Merck; Pfizer; Procter & Gamble
Research Funding - AstraZeneca (Inst)
 
Desiree Iriarte
Research Funding - AstraZeneca (Inst)
 
Heather Sloan
No Relationships to Disclose
 
Cara Wiseman
Research Funding - AstraZeneca (Inst)
 
James Moon
No Relationships to Disclose
 
Gary E. Goodman
No Relationships to Disclose
 
Amy Bondurant
No Relationships to Disclose
 
Daniel Veljovich
Speakers' Bureau - Genentech; Intuitive Surgical
Other Relationship - Intuitive Surgical
 
Peter Y. Z. Jiang
No Relationships to Disclose
 
Tanya A. Wahl
No Relationships to Disclose
 
Chirag Shah
Stock and Other Ownership Interests - Intuitive Surgical
Speakers' Bureau - Genentech
 
Charles Drescher
No Relationships to Disclose
 
Henry G. Kaplan
Stock and Other Ownership Interests - Abbvie; Biogen; Gilead Sciences; GlaxoSmithKline; Pfizer
 
William A. Peters
Speakers' Bureau - Genentech
 
Erin Ellis
No Relationships to Disclose
 
Mehmet F. Fer
No Relationships to Disclose
 
Min S. Park
No Relationships to Disclose
 
Eileen Johnston
No Relationships to Disclose